Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Diseases

  Free Subscription


Articles published in Br J Surg

Retrieve available abstracts of 103 articles:
HTML format



Single Articles


    July 2021
  1. HOBEIKA C, Cauchy F
    Reply: Commentary on 'laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis'.
    Br J Surg. 2021 Jul 16. pii: 6322942. doi: 10.1093.
    PubMed    


    June 2021
  2. WEI F
    Comment on: Laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis.
    Br J Surg. 2021 Jun 14. pii: 6298428. doi: 10.1093.
    PubMed    


    May 2021
  3. LAYTON GR, Chung WY, Isherwood J, Fraser RE, et al
    Endoscopic retrograde cholangiopancreatography in the COVID era: considerations for hepatobiliary and pancreatic surgery units.
    Br J Surg. 2021 May 17. pii: 6277144. doi: 10.1093.
    PubMed    


  4. HOBEIKA C, Cauchy F
    Reply: Can laparoscopic approach improve quality of care of patients with resectable intrahepatic cholangiocarcinoma? (Comment on 'laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis').
    Br J Surg. 2021 May 17. pii: 6277143. doi: 10.1093.
    PubMed    


    April 2021

  5. Ingested fishbone causing a hepatic abscess.
    Br J Surg. 2021 Apr 19. pii: 6238564. doi: 10.1093.
    PubMed    


    March 2021
  6. TSILIMIGRAS DI, Pawlik TM
    Prognostication in hepatocellular carcinoma: is it a burden or a ticket?
    Br J Surg. 2021 Mar 18. pii: 6177466. doi: 10.1093.
    PubMed    


  7. LANG H
    Should all intrahepatic cholangiocarcinomas receive neoadjuvant chemotherapy before resection?
    Br J Surg. 2021 Mar 16. pii: 6173022. doi: 10.1093.
    PubMed    


  8. TROISI RI, Berardi G, Morise Z, Cipriani F, et al
    Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study.
    Br J Surg. 2021;108:196-204.
    PubMed     Abstract available


  9. TAKAICHI S, Tomimaru Y, Kobayashi S, Takeda Y, et al
    Drainage after laparoscopic liver surgery in the CSGO-HBP-004 study: propensity score-matched analysis.
    Br J Surg. 2021;108:e57-e58.
    PubMed    


  10. HEIL J, Korenblik R, Heid F, Bechstein WO, et al
    Preoperative portal vein or portal and hepatic vein embolization: DRAGON collaborative group analysis.
    Br J Surg. 2021 Mar 1. pii: 6154479. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  11. TAKAYAMA T, Yamazaki S, Matsuyama Y, Midorikawa Y, et al
    Prognostic grade for resecting hepatocellular carcinoma: multicentre retrospective study.
    Br J Surg. 2021 Jan 31. pii: 6124821. doi: 10.1093.
    PubMed     Abstract available


  12. VAILAS M, Sotiropoulou M, Maroulis I
    Changing surgical practice in management of intrahepatic cholangiocarcinoma during the pandemic. Is bridging with systemic therapy safe for our patients?
    Br J Surg. 2021 Jan 27. pii: 6126379. doi: 10.1093.
    PubMed    


  13. HOBEIKA C, Cauchy F, Fuks D, Barbier L, et al
    Laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis.
    Br J Surg. 2021 Jan 24. pii: 6118366. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  14. LIN JY, Fang CH, Yang J
    Comment on: Right hepatic venous system variation in living donors: a three-dimensional CT analysis.
    Br J Surg. 2020 Oct 7. doi: 10.1002/bjs.11985.
    PubMed    


  15. HOBEIKA C, Soubrane O, Cauchy F
    Author response to: The intra-hepatic venous network in liver cirrhosis.
    Br J Surg. 2020 Oct 1. doi: 10.1002/bjs.11973.
    PubMed    


    September 2020
  16. WATANABE A, Harimoto N, Kogure K, Shirabe K, et al
    Author response to: Comment on: Right hepatic venous system variation in living donors: a three-dimensional CT analysis.
    Br J Surg. 2020 Sep 29. doi: 10.1002/bjs.11983.
    PubMed    


  17. MANENTI A, Roncati L, Manco G, Farinetti A, et al
    The intra-hepatic venous network in liver cirrhosis.
    Br J Surg. 2020 Sep 26. doi: 10.1002/bjs.11974.
    PubMed    


  18. HUO TI, Liu PH, Hsu CY
    Tumour burden score for hepatocellular carcinoma: Is it an authentic prognostic marker?
    Br J Surg. 2020 Sep 21. doi: 10.1002/bjs.11927.
    PubMed    


  19. TSILIMIGRAS DI, Pawlik TM
    Tumour Burden Score: An Authentic, Easy-To-Use Prognostic Marker for Hepatocellular Carcinoma.
    Br J Surg. 2020 Sep 21. doi: 10.1002/bjs.11926.
    PubMed    


  20. WATANABE A, Harimoto N, Kogure K, Shirabe K, et al
    Author response to: Comment on: Right hepatic venous system variation in living donors: a three-dimensional CT analysis.
    Br J Surg. 2020 Sep 16. doi: 10.1002/bjs.11825.
    PubMed    


  21. ANDEL D, Dassen MG, Reinders-Hut MTM, Peters NA, et al
    Surgical outcomes of major hepatectomy following "radiation lobectomy" for hepatic malignancies and insufficiently functional future liver remnant: initial experience.
    Br J Surg. 2020 Sep 16. doi: 10.1002/bjs.11828.
    PubMed    


  22. YAN J, Yang C, Bu J, Hu X, et al
    Comment on: Right hepatic venous system variation in living donors: a three-dimensional CT analysis.
    Br J Surg. 2020 Sep 13. doi: 10.1002/bjs.11826.
    PubMed    


    August 2020
  23. MOHAMED F, Kallioinen M, Braun M, Fenwick S, et al
    Author response to: NICE Guidelines: management of colorectal cancer metastases.
    Br J Surg. 2020;107:e358.
    PubMed    


    July 2020
  24. BAUM M, Fallowfield L, Farewell V, Macbeth F, et al
    NICE Guidelines: management of colorectal cancer metastases.
    Br J Surg. 2020 Jul 11. doi: 10.1002/bjs.11789.
    PubMed    


    June 2020
  25. ROMPIANESI G, Shankar S, Reddy S, Silva M, et al
    Caught in the crossfire: hepato-bilio-pancreatic cancer surgery in the midst of COVID-19.
    Br J Surg. 2020 Jun 22. doi: 10.1002/bjs.11764.
    PubMed    


  26. NEVERMANN NF, Hillebrandt KH, Knitter S, Ritschl PV, et al
    COVID-19 pandemic: implications on the surgical treatment of gastrointestinal and hepatopancreatobiliary tumours in Europe.
    Br J Surg. 2020 Jun 10. doi: 10.1002/bjs.11751.
    PubMed    


  27. WIGMORE SJ
    Advances in liver surgery.
    Br J Surg. 2020;107:788-789.
    PubMed    


  28. OLTHOF PB, Elfrink AKE, Marra E, Belt EJT, et al
    Volume-outcome relationship of liver surgery: a nationwide analysis.
    Br J Surg. 2020;107:917-926.
    PubMed     Abstract available


    May 2020
  29. MOHAMED F, Kallioinen M, Braun M, Fenwick S, et al
    Management of colorectal cancer metastases to the liver, lung or peritoneum suitable for curative intent: summary of NICE guidance.
    Br J Surg. 2020 May 9. doi: 10.1002/bjs.11609.
    PubMed    


    April 2020
  30. WATANABE A, Yoshizumi T, Harimoto N, Kogure K, et al
    Right hepatic venous system variation in living donors: a three-dimensional CT analysis.
    Br J Surg. 2020 Apr 26. doi: 10.1002/bjs.11602.
    PubMed     Abstract available


  31. ZHANG XP, Wang K, Gao YZ, Wei XB, et al
    Prognostic model for identifying candidates for hepatectomy among patients with hepatocellular carcinoma and hepatic vein invasion.
    Br J Surg. 2020 Apr 4. doi: 10.1002/bjs.11524.
    PubMed     Abstract available


  32. KOK END, Havenga K, Tanis PJ, de Wilt JHW, et al
    Multicentre study of short-course radiotherapy, systemic therapy and resection/ablation for stage IV rectal cancer.
    Br J Surg. 2020;107:537-545.
    PubMed     Abstract available


    March 2020
  33. WALLACE D, Cowling TE, Walker K, Suddle A, et al
    Liver transplantation outcomes after transarterial chemotherapy for hepatocellular carcinoma.
    Br J Surg. 2020 Mar 28. doi: 10.1002/bjs.11559.
    PubMed     Abstract available


  34. WALLACE D, Cowling TE, Walker K, Suddle A, et al
    Short- and long-term mortality after liver transplantation in patients with and without hepatocellular carcinoma in the UK.
    Br J Surg. 2020 Mar 3. doi: 10.1002/bjs.11451.
    PubMed     Abstract available


  35. HOBEIKA C, Cauchy F, Sartoris R, Beaufrere A, et al
    Relevance of liver surface nodularity for preoperative risk assessment in patients with resectable hepatocellular carcinoma.
    Br J Surg. 2020 Mar 2. doi: 10.1002/bjs.11511.
    PubMed     Abstract available


  36. AOKI T, Kubota K, Kubo S, Kudo M, et al
    Author response to: Comment on: Significance of the surgical hepatic resection margin in patients with a single hepatocellular carcinoma.
    Br J Surg. 2020;107:465.
    PubMed    


  37. CAI YS, Zhang BH, Hou GM, Yang JY, et al
    Comment on: Significance of the surgical hepatic resection margin in patients with a single hepatocellular carcinoma.
    Br J Surg. 2020;107:469-470.
    PubMed    


  38. LIU R, Zhang XP
    Comment on: Significance of the surgical hepatic resection margin in patients with a single hepatocellular carcinoma.
    Br J Surg. 2020;107:464-465.
    PubMed    


  39. AOKI T, Kubota K, Kubo S, Kudo M, et al
    Author response to: Comment on: Significance of the surgical hepatic resection margin in patients with a single hepatocellular carcinoma.
    Br J Surg. 2020;107:470.
    PubMed    


  40. VIGANO L, Cimino M, Aldrighetti L, Ferrero A, et al
    Multicentre evaluation of case volume in minimally invasive hepatectomy.
    Br J Surg. 2020;107:443-451.
    PubMed     Abstract available


    February 2020
  41. TSILIMIGRAS DI, Moris D, Hyer JM, Bagante F, et al
    Hepatocellular carcinoma tumour burden score to stratify prognosis after resection.
    Br J Surg. 2020 Feb 14. doi: 10.1002/bjs.11464.
    PubMed     Abstract available


  42. YAN J, Feng H, Wang H, Yuan F, et al
    Hepatic artery classification based on three-dimensional CT.
    Br J Surg. 2020 Feb 14. doi: 10.1002/bjs.11458.
    PubMed     Abstract available


  43. KAWAGUCHI Y, Hasegawa K, Tzeng CD, Mizuno T, et al
    Performance of a modified three-level classification in stratifying open liver resection procedures in terms of complexity and postoperative morbidity.
    Br J Surg. 2020;107:258-267.
    PubMed     Abstract available


    January 2020
  44. MORISE Z, Aldrighetti L, Belli G, Ratti F, et al
    Laparoscopic repeat liver resection for hepatocellular carcinoma: a multicentre propensity score-based study.
    Br J Surg. 2020 Jan 29. doi: 10.1002/bjs.11436.
    PubMed     Abstract available


  45. MARTEL G, Baker L, Wherrett C, Fergusson DA, et al
    Phlebotomy resulting in controlled hypovolaemia to prevent blood loss in major hepatic resections (PRICE-1): a pilot randomized clinical trial for feasibility.
    Br J Surg. 2020 Jan 22. doi: 10.1002/bjs.11463.
    PubMed     Abstract available


  46. HOBEIKA C, Fuks D, Cauchy F, Goumard C, et al
    Impact of cirrhosis in patients undergoing laparoscopic liver resection in a nationwide multicentre survey.
    Br J Surg. 2020 Jan 9. doi: 10.1002/bjs.11406.
    PubMed     Abstract available


  47. SCHNITZBAUER AA
    Author response to: Beyond the scalpel - mortality after liver surgery in patients with liver metastases - time to rethink the indications: Total quality control and just culture for oncologic therapies urgently required!
    Br J Surg. 2020;107:149-150.
    PubMed    


  48. BODA-HEGGEMANN J, Hofheinz R, Gkika E, Brunner T, et al
    Beyond the scalpel - mortality after liver surgery in patients with liver metastases - time to rethink the indications.
    Br J Surg. 2020;107:149.
    PubMed    


    October 2019
  49. AOKI T, Kubota K, Hasegawa K, Kubo S, et al
    Significance of the surgical hepatic resection margin in patients with a single hepatocellular carcinoma.
    Br J Surg. 2019 Oct 25. doi: 10.1002/bjs.11329.
    PubMed     Abstract available


  50. BERARDI G, Aghayan D, Fretland AA, Elberm H, et al
    Multicentre analysis of the learning curve for laparoscopic liver resection of the posterosuperior segments.
    Br J Surg. 2019;106:1512-1522.
    PubMed     Abstract available


  51. FILMANN N, Walter D, Schadde E, Bruns C, et al
    Mortality after liver surgery in Germany.
    Br J Surg. 2019;106:1523-1529.
    PubMed     Abstract available


    September 2019
  52. FRETLAND AA, Dagenborg VJ, Waaler Bjornelv GM, Aghayan DL, et al
    Quality of life from a randomized trial of laparoscopic or open liver resection for colorectal liver metastases.
    Br J Surg. 2019;106:1372-1380.
    PubMed     Abstract available


    August 2019
  53. TANAKA M, Mihaljevic AL, Probst P, Heckler M, et al
    Meta-analysis of recurrence pattern after resection for pancreatic cancer.
    Br J Surg. 2019 Aug 27. doi: 10.1002/bjs.11295.
    PubMed     Abstract available


  54. GARLIPP B, Gibbs P, Van Hazel GA, Jeyarajah R, et al
    Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial.
    Br J Surg. 2019 Aug 19. doi: 10.1002/bjs.11283.
    PubMed     Abstract available


  55. BACHET JB, Moreno-Lopez N, Vigano L, Marchese U, et al
    BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases.
    Br J Surg. 2019;106:1237-1247.
    PubMed     Abstract available


    July 2019
  56. VAN ROSMALEN BV, Klompenhouwer AJ, de Graeff JJ, Haring MPD, et al
    Safety and efficacy of transarterial embolization of hepatocellular adenomas.
    Br J Surg. 2019 Jul 17. doi: 10.1002/bjs.11213.
    PubMed     Abstract available


  57. YANG T, Liu K, Liu CF, Zhong Q, et al
    Impact of postoperative infective complications on long-term survival after liver resection for hepatocellular carcinoma.
    Br J Surg. 2019 Jul 5. doi: 10.1002/bjs.11231.
    PubMed     Abstract available


    June 2019
  58. CHEN AH, Chan WH, Lee YH, Tseng JH, et al
    Routine chest CT for staging of gastric cancer.
    Br J Surg. 2019 Jun 18. doi: 10.1002/bjs.11186.
    PubMed     Abstract available


    May 2019
  59. VAN DER POEL MJ, Barkhatov L, Fuks D, Berardi G, et al
    Multicentre propensity score-matched study of laparoscopic versus open repeat liver resection for colorectal liver metastases.
    Br J Surg. 2019;106:783-789.
    PubMed     Abstract available


    April 2019
  60. TAKEMURA N, Aoki T, Hasegawa K, Kaneko J, et al
    Hepatectomy for hepatocellular carcinoma after perioperative management of portal hypertension.
    Br J Surg. 2019 Apr 16. doi: 10.1002/bjs.11153.
    PubMed     Abstract available


    January 2019
  61. BJORNELV GMW, Dueland S, Line PD, Joranger P, et al
    Cost-effectiveness of liver transplantation in patients with colorectal metastases confined to the liver.
    Br J Surg. 2019;106:132-141.
    PubMed     Abstract available


    September 2018
  62. YU JJ, Shen F, Chen TH, Liang L, et al
    Multicentre study of the prognostic impact of preoperative bodyweight on long-term prognosis of hepatocellular carcinoma.
    Br J Surg. 2018 Sep 10. doi: 10.1002/bjs.10981.
    PubMed     Abstract available


  63. MEHRABI A, Golriz M, Khajeh E, Ghamarnejad O, et al
    Meta-analysis of the prognostic role of perioperative platelet count in posthepatectomy liver failure and mortality.
    Br J Surg. 2018;105:1254-1261.
    PubMed     Abstract available


    August 2018
  64. FRITZMANN J, Kirchberg J, Sturm D, Ulrich AB, et al
    Randomized clinical trial of stapler hepatectomy versus LigaSure transection in elective hepatic resection.
    Br J Surg. 2018;105:1119-1127.
    PubMed     Abstract available


  65. HALLS MC, Berardi G, Cipriani F, Barkhatov L, et al
    Development and validation of a difficulty score to predict intraoperative complications during laparoscopic liver resection.
    Br J Surg. 2018;105:1182-1191.
    PubMed     Abstract available


  66. MARGONIS GA, Sasaki K, Gholami S, Kim Y, et al
    Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases.
    Br J Surg. 2018;105:1210-1220.
    PubMed     Abstract available


  67. SATO N, Kenjo A, Kimura T, Okada R, et al
    Prediction of major complications after hepatectomy using liver stiffness values determined by magnetic resonance elastography.
    Br J Surg. 2018;105:1192-1199.
    PubMed     Abstract available


  68. OKUNO M, Goumard C, Mizuno T, Kopetz S, et al
    Prognostic impact of perihepatic lymph node metastases in patients with resectable colorectal liver metastases.
    Br J Surg. 2018;105:1200-1209.
    PubMed     Abstract available


    May 2018
  69. YAMASHITA S, Chun YS, Kopetz SE, Vauthey JN, et al
    Biomarkers in colorectal liver metastases.
    Br J Surg. 2018;105:618-627.
    PubMed     Abstract available


    April 2018
  70. ZHANG XF, Chakedis J, Bagante F, Chen Q, et al
    Trends in use of lymphadenectomy in surgery with curative intent for intrahepatic cholangiocarcinoma.
    Br J Surg. 2018 Apr 14. doi: 10.1002/bjs.10827.
    PubMed     Abstract available


    March 2018
  71. DUELAND S, Foss A, Solheim JM, Hagness M, et al
    Survival following liver transplantation for liver-only colorectal metastases compared with hepatocellular carcinoma.
    Br J Surg. 2018 Mar 13. doi: 10.1002/bjs.10769.
    PubMed     Abstract available


    February 2018
  72. GELLI M, Allard MA, Farges O, Paugam-Burtz C, et al
    Use of aspirin and bleeding-related complications after hepatic resection.
    Br J Surg. 2018 Feb 7. doi: 10.1002/bjs.10697.
    PubMed     Abstract available


  73. STUDER P, Horn T, Haynes A, Candinas D, et al
    Quality of life after hepatic resection.
    Br J Surg. 2018;105:237-243.
    PubMed     Abstract available


  74. GRUT H, Solberg S, Seierstad T, Revheim ME, et al
    Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases.
    Br J Surg. 2018;105:295-301.
    PubMed     Abstract available


    December 2017

  75. Multicentre study of the impact of morbidity on long-term survival following hepatectomy for intrahepatic cholangiocarcinoma.
    Br J Surg. 2017;104:1895.
    PubMed    


    November 2017
  76. ZHANG XF, Beal EW, Bagante F, Chakedis J, et al
    Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent.
    Br J Surg. 2017 Nov 28. doi: 10.1002/bjs.10676.
    PubMed     Abstract available


  77. ROBERTS SE, Brown TH, Thorne K, Lyons RA, et al
    Weekend admission and mortality for gastrointestinal disorders across England and Wales.
    Br J Surg. 2017;104:1723-1734.
    PubMed     Abstract available


  78. NG KKC, Chok KSH, Chan ACY, Cheung TT, et al
    Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma.
    Br J Surg. 2017 Nov 1. doi: 10.1002/bjs.10677.
    PubMed     Abstract available


    October 2017
  79. ELLEBAEK SB, Fristrup CW, Hovendal C, Qvist N, et al
    Randomized clinical trial of laparoscopic ultrasonography before laparoscopic colorectal cancer resection.
    Br J Surg. 2017;104:1462-1469.
    PubMed     Abstract available


    August 2017
  80. LE ROY B, Gelli M, Pittau G, Allard MA, et al
    Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma.
    Br J Surg. 2017 Aug 31. doi: 10.1002/bjs.10641.
    PubMed     Abstract available


  81. KLOMPENHOUWER AJ, Broker MEE, Thomeer MGJ, Gaspersz MP, et al
    Retrospective study on timing of resection of hepatocellular adenoma.
    Br J Surg. 2017 Aug 30. doi: 10.1002/bjs.10594.
    PubMed     Abstract available


    July 2017
  82. CUCCHETTI A, Mazzaferro V, Pinna AD, Sposito C, et al
    Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma.
    Br J Surg. 2017 Jul 26. doi: 10.1002/bjs.10613.
    PubMed     Abstract available


  83. ZHAO J, van Mierlo KMC, Gomez-Ramirez J, Kim H, et al
    Systematic review of the influence of chemotherapy-associated liver injury on outcome after partial hepatectomy for colorectal liver metastases.
    Br J Surg. 2017;104:990-1002.
    PubMed     Abstract available


    June 2017
  84. ERRIDGE S, Pucher PH, Markar SR, Malietzis G, et al
    Meta-analysis of determinants of survival following treatment of recurrent hepatocellular carcinoma.
    Br J Surg. 2017 Jun 19. doi: 10.1002/bjs.10597.
    PubMed     Abstract available


  85. VAN ROSMALEN BV, Coelen RJS, Bieze M, van Delden OM, et al
    Systematic review of transarterial embolization for hepatocellular adenomas.
    Br J Surg. 2017;104:823-835.
    PubMed     Abstract available


  86. SASAKI K, Margonis GA, Andreatos N, Wilson A, et al
    Prognostic impact of margin status in liver resections for colorectal metastases after bevacizumab.
    Br J Surg. 2017;104:926-935.
    PubMed     Abstract available


    May 2017
  87. KIM H, Ahn SW, Hong SK, Yoon KC, et al
    Survival benefit of liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma.
    Br J Surg. 2017 May 8. doi: 10.1002/bjs.10541.
    PubMed     Abstract available


  88. ODISIO BC, Yamashita S, Huang SY, Harmoush S, et al
    Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status.
    Br J Surg. 2017;104:760-768.
    PubMed     Abstract available


  89. SCUDERI V, Barkhatov L, Montalti R, Ratti F, et al
    Outcome after laparoscopic and open resections of posterosuperior segments of the liver.
    Br J Surg. 2017;104:751-759.
    PubMed     Abstract available


    April 2017
  90. ANGELSEN JH, Horn A, Sorbye H, Eide GE, et al
    Population-based study on resection rates and survival in patients with colorectal liver metastasis in Norway.
    Br J Surg. 2017;104:580-589.
    PubMed     Abstract available


  91. IMAI K, Allard MA, Castro Benitez C, Vibert E, et al
    Long-term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases.
    Br J Surg. 2017;104:570-579.
    PubMed     Abstract available


    March 2017
  92. LEMKE M, Law CH, Li J, Dixon E, et al
    Three-point transfusion risk score in hepatectomy.
    Br J Surg. 2017;104:434-442.
    PubMed     Abstract available


    January 2017
  93. BERTUZZO VR, Giannella M, Cucchetti A, Pinna AD, et al
    Impact of preoperative infection on outcome after liver transplantation.
    Br J Surg. 2017;104:e172-e181.
    PubMed     Abstract available


  94. DASKALAKIS K, Karakatsanis A, Stalberg P, Norlen O, et al
    Clinical signs of fibrosis in small intestinal neuroendocrine tumours.
    Br J Surg. 2017;104:69-75.
    PubMed     Abstract available


    December 2016
  95. ICHIDA A, Hasegawa K, Takayama T, Kudo H, et al
    Randomized clinical trial comparing two vessel-sealing devices with crush clamping during liver transection.
    Br J Surg. 2016;103:1795-1803.
    PubMed     Abstract available


    October 2016
  96. ADAM R, Imai K, Castro Benitez C, Allard MA, et al
    Outcome after associating liver partition and portal vein ligation for staged hepatectomy and conventional two-stage hepatectomy for colorectal liver metastases.
    Br J Surg. 2016;103:1521-9.
    PubMed     Abstract available


  97. CIPRIANI F, Rawashdeh M, Stanton L, Armstrong T, et al
    Propensity score-based analysis of outcomes of laparoscopic versus open liver resection for colorectal metastases.
    Br J Surg. 2016;103:1504-12.
    PubMed     Abstract available


  98. CHERQUI D
    Evolution of laparoscopic liver resection.
    Br J Surg. 2016;103:1405-7.
    PubMed    


    September 2016
  99. HALLET J, Sa Cunha A, Adam R, Goere D, et al
    Factors influencing recurrence following initial hepatectomy for colorectal liver metastases.
    Br J Surg. 2016;103:1366-76.
    PubMed     Abstract available


    July 2016
  100. HOF J, Wertenbroek MW, Peeters PM, Widder J, et al
    Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases.
    Br J Surg. 2016;103:1055-62.
    PubMed     Abstract available


  101. PHILIPS P, Groeschl RT, Hanna EM, Swan RZ, et al
    Single-stage resection and microwave ablation for bilobar colorectal liver metastases.
    Br J Surg. 2016;103:1048-54.
    PubMed     Abstract available


    June 2016
  102. MCCARTAN DP, Prichard RS, MacDermott RJ, Rothwell J, et al
    Role of bone scan in addition to CT in patients with breast cancer selected for systemic staging.
    Br J Surg. 2016;103:839-44.
    PubMed     Abstract available


  103. MARGONIS GA, Amini N, Buettner S, Besharati S, et al
    Impact of early postoperative platelet count on volumetric liver gain and perioperative outcomes after major liver resection.
    Br J Surg. 2016;103:899-907.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: